Fourteen pediatric cases of myelodysplastic syndrome according to French-Am
erican-British Cooperative Group (FAB) criteria were identified in a retros
pective review of all cases of hematologic malignancies referred to the Ped
iatric Oncology division of the Cancer Hospital A. C. Camargo over a 12-yea
r period: 1 case of refractory anemia, 8 cases of refractory anemia with ex
cess of blasts, and 1 case of refractory anemia with excess of blasts in tr
ansformation. Three children had features consistent with chronic myelomono
cytic leukemia, and one child was diagnosed with secondary myelodysplastic
syndrome. The median age was 3.5 years (1 month-11 years). In 11/14 casus t
he disease evolved to acute leukemia. In 3 patients blasts had morphologica
l and cytochemical features of lymphoblasts. Two of these patients had a go
od response to acute lymphoblastic leukemia chemotherapy protocol. The time
of progression to leukemia in these cases was shorter than in those who ev
olved to acute myeloid leukemia. The authors believe this to be the first s
eries of pediatric myelodysplastic syndrome documented in Brazil. Cases wer
e characterized by aggressive FAB type, conspicuous cell atypias in all 3 h
emopioetic cell fines, and a high rate of evolution to acute leukemia.